According to a new report, published by KBV research, The Global Capnography Equipment Market size is expected to reach $451.8 million by 2028, rising at a market growth of 4.6% CAGR during the forecast period.
The Mainstream segment acquired maximum revenue share in the Global Capnography Equipment Market by Technology in 2021, thereby, achieving a market value of $300.5 million by 2028. The benefits associated with mainstream capnography, including the convenience of use and the ability to precisely monitor breathing in intubated patients, are likely to boost the growth of this segment.
The Trauma & Emergency Care segment is showcasing a CAGR of 4.8% during (2022 - 2028). Capnography equipment is commonly used in emergency medicine to improve prehospital ventilation and manage pediatric emergencies, as well as in ambulatory care centers and as a pulmonary blood flow prognostic indicator. In addition, the American Heart Association (AHA) and the European Resuscitation Council are developing guidelines and recommendations to integrate capnography in emergency care to increase patients' chances of survival, which is driving demand for capnographs.
The Hospitals segment is leading the Global Capnography Equipment Market by End User in 2021, thereby, achieving a market value of $339.7 million by 2028. In the coming years, factors such as changing recommendations for capnography use and the increased frequency of chronic illnesses are projected to boost the demand for capnography equipment in hospital settings. The product is utilized in ICUs as a preventative step to deal with critical events. Due to its ease of use, less invasive nature, and improved capabilities for computing patient-ventilator measurements, capnography methods are widely used in hospital settings. This is mostly due to an increase in the number of cardiac arrests, which is expected to increase the demand for adequate patient monitoring.
The Capnometers segment has shown growth rate of 6.7% during (2022 - 2028). Capnometry is a noninvasive measurement of systemic metabolism, circulation, and ventilation that quantifies carbon dioxide in exhaled air. The capnometer should show a decrease in PaCO2, and the patient may or may not experience the onset of symptoms. Capnometry is a noninvasive measurement of systemic metabolism, circulation, and ventilation that quantifies carbon dioxide in exhaled air.
North America is the fastest growing region in the Global Capnography Equipment Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $212.0 million by 2028. The Europe market is estimated to witness a CAGR of 5% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 5.3% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/capnography-equipment-market/
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Masimo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Medtronic PLC, General Electric (GE) Co. (GE Healthcare), Dragerwerk AG & Co. KGaA, Asahi Kasei Corporation (Zoll Medical Corporation), Hamilton Medical AG (Hamilton Bonaduz AG), Edan Instruments, Inc., and Nihon Kohden Corporation.
By Technology
By Application
By End User
By Product
By Geography
Companies Profiled
Unique Offerings 
